Skip to main content
Tawanda Gumbo, MD, Infectious Disease, Dallas, TX, Parkland Health

TawandaGumboMD

Infectious Disease • Dallas, TX

Mycobacterial Disease

Director of Research Programs in Global Health & Associate Professor of Medicine

Join to view full profile

Dr. Gumbo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gumbo's full profile

Already have an account?

  • Office

    University of Texas Southwestern Medical Ctr
    5323 Harry Hines Blvd
    Dallas, TX 75390
    Phone+1 214-648-9914
    Fax+1 214-648-2741
  • Is this information wrong?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Infectious Disease, 1996 - 1999
  • The MetroHealth System/Case Western Reserve University
    The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1993 - 1996
  • University of Zimbabwe Huggins SOM
    University of Zimbabwe Huggins SOMClass of 1991

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2009 - 2018

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Oxford University Press Has Registered This DOI Pre-Publication  
    Devyani Deshpande, Tawanda Gumbo, Oxford University Press
  • Oxford University Press Has Registered This DOI Pre-Publication  
    Tawanda Gumbo, MD, Oxford University Press
  • Oxford University Press Has Registered This DOI Pre-Publication  
    Tawanda Gumbo, Devyani Deshpande, Oxford University Press
  • Join now to see all

Abstracts/Posters

  • Oxford University Press Has Registered This DOI Pre-Publication
    Tawanda Gumbo, MD, Oxford University Press, Orlando, FL, 12/7/2019

Press Mentions

  • Praedicare Inc. Receives Grant to Evaluate Potential New Drug Regimens for Tuberculosis
    Praedicare Inc. Receives Grant to Evaluate Potential New Drug Regimens for TuberculosisJune 17th, 2021
  • New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB Treatment
    New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020
  • New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB Treatment
    New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020
  • Join now to see all

Grant Support

  • PK-PD Of Combination Antituberculosis Therapy For Suppression Of Drug-ResistanceNational Institute Of Allergy And Infectious Diseases2008–2011
  • Efflux PUMP Inhibitors To Reduce Duration Of Antituberculosis TherapyOffice Of The Director, National Institutes Of Health2007

Hospital Affiliations

Dr. Tawanda Gumbo, Dr. Tawanda Gumbo, MD, Dr. T Gumbo